Answers are grounded in this paper and cite their sources.
Narrative review outlines the therapeutic efficacy and pharmacology of adriamycin across diverse malignancies, highlighting its role as a broad-spectrum chemotherapeutic.
Stephen K. Carter, M.D.; Adriamycin—A Review, JNCI: Journal of the National Cancer Institute, Volume 55, Issue 6, 1 December 1975, Pages 1265–1274, https://doi.
No takes yet. Share an insight, caveat, or question.
Stephen K. Carter (1975) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: